Wanbury receives term loan facilities of Rs 60 crore from Tata Capital

27 Jun 2024 Evaluate

Wanbury has received a term loan facilities of Rs 60 crore from Tata Capital, Mumbai at 12.50% interest per annum repayable over a period of seven years. The funds received by the company will be utilized towards the long-term working capital and capex requirement. 

Wanbury, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation.


Wanbury Share Price

218.75 7.75 (3.67%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.